Evidence map›Paper›PMID 9329959›Full record

ArticleThe Journal of clinical investigation1997

Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice.

M C Colbert, D G Hall, T R Kimball, S A Witt, J N Lorenz, M L Kirby, T E Hewett, R Klevitsky, J Robbins

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Gene expression profiling of dilated cardiomyopathy in older male EP4 knockout mice.American journal of physiology. Heart and circulatory physiology · 2010
    Article
  17. Review
  18. Article
  19. Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

M C ColbertDivision of Molecular Cardiovascular Biology, Children's Hospital Research Foundation, Cincinnati, Ohio 45229-3039, USA. melissa.colbert@chmcc.org
D G Hall
T R Kimball
S A Witt
J N Lorenz
M L Kirby
T E Hewett
R Klevitsky
J Robbins
Cincinnati Children's Hospital Medical Center · USGeorgia College & State University · USInstitute of Molecular Genetics · RUOrthopedic One · USUniversity of Cincinnati · US

Funding

SPATIAL RELATIONSHIPS IN CARDIAC TROPONIN--ACIDOSIS AND PHOSPHORYLATIONP01HL041496 · NHLBI · UNIVERSITY OF CINCINNATI · PI ROBBINS, JEFFREY · 1988 to 2000
$2.6M
TRANSGENIC REMODELING OF THE RABBIT HEARTR01HL056370 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI ROBBINS, JEFFREY · 1996 to 2006
$1.4M
IN VIVO ANALYSIS OF MYOCARDIAL RESPONSE TO RETINOIC ACIDR01HL055904 · NHLBI · CHILDREN'S HOSPITAL MED CTR (CINCINNATI) · PI COLBERT, MELISSA C. · 1995 to 1998
–
NHLBI NIH HHS HL41496NHLBI NIH HHS HL-55904NHLBI NIH HHS HL56370
6 · The paper itself

Abstract

Retinoids play a critical role in cardiac morphogenesis. To examine the effects of excessive retinoid signaling on myocardial development, transgenic mice that overexpress a constitutively active retinoic acid receptor (RAR) controlled by either the alpha- or beta-myosin heavy chain (MyHC) promoter were generated. Animals carrying the alpha-MyHC-RAR transgene expressed RARs in embryonic atria and in adult atria and ventricles, but developed no signs of either malformations or disease. In contrast, beta-MyHC-RAR animals, where expression was activated in fetal ventricles, developed a dilated cardiomyopathy that varied in severity with transgene copy number. Characteristic postmortem lesions included biventricular chamber dilation and left atrial thrombosis; the incidence and severity of these lesions increased with increasing copy number. Transcript analyses showed that molecular markers of hypertrophy, alpha-skeletal actin, atrial natriuretic factor and beta-MyHC, were upregulated. Cardiac performance of transgenic hearts was evaluated using the isolated perfused working heart model as well as in vivo, by transthoracic M-mode echocardiography. Both analyses showed moderate to severe impairment of left ventricular function and reduced cardiac contractility. Thus, expression of a constitutively active RAR in developing atria and/ or in postnatal ventricles is relatively benign, while ventricular expression during gestation can lead to significant cardiac dysfunction.

Indexed as

AnimalsCardiomyopathy, DilatedEchocardiographyFemaleGene DosageGene ExpressionGene TargetingHeartHeart Defects, CongenitalHeart FailureMaleMiceMice, TransgenicMyocardiumMyosin Heavy ChainsPromoter Regions, GeneticMyosin Heavy ChainsReceptors, Retinoic Acid

Identifiers

PMID9329959
PMCPMC508385
OpenAlexW2052306269

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.